Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. 1985 August; 76(2): 403–412.
PMCID: PMC423826

Apolipoprotein B-100 deficiency. Intestinal steatosis despite apolipoprotein B-48 synthesis.


We describe a child, the issue of phenotypically normal parents, who had fat malabsorption, both intestinal and hepatic steatosis, and serum cholesterol and triglyceride concentrations of 38 and 63 mg/dl, respectively. Lipoprotein electrophoresis, Ouchterlony double diffusion, and electron microscopy demonstrated that normal low density lipoproteins (LDL: 1.006 less than rho less than 1.063 g/ml) were absent. Lipoprotein particles in the rho less than 1.006-g/ml fraction were triglyceride rich, very large (93.2 +/- 35.1 nm), and contained the B-48 but not the B-100 apoprotein; both species of apolipoprotein (apo) B were found in the parents' lipoproteins. These chylomicrons and chylomicron remnants were present even in the patient's fasting plasma, which suggested prolonged dietary fat absorption. Plasma levels of high density lipoprotein lipids and proteins were low, and the phosphatidylcholine/sphingomyelin ratio was reduced as in typical abetalipoproteinemia. The monosialylated form of apo C-III was not identified on polyacrylamide gel electrophoresis, which suggested that this protein was elaborated only with very low density lipoproteins (VLDL). A radioimmunoassay for apo B employing a polyclonal antisera to plasma LDL gave apparent plasma apo B levels of 0.6, 66, and 57 mg/dl in the patient and his father and mother, respectively. The displacement curve generated by the parents' VLDL and LDL did not did not differ from control lipoproteins. The patient's chylomicron-chylomicron remnant fraction displaced normal LDL over the entire radioimmunoassay range, but the efficiency of displacement was strikingly less than with B-100 containing lipoproteins. If the patient's B-48 protein is not qualitatively abnormal, these results confirm very limited immunochemical cross-reactivity between at least one major epitope on B-100 and the epitopes expressed on B-48. The apo B defect in this patient appears to be recessive. It abolishes B-100 production and may additionally limit the formation of B-48.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (3.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Malloy MJ, Kane JP. Hypolipidemia. Med Clin North Am. 1982 Mar;66(2):469–484. [PubMed]
  • Kane JP, Hardman DA, Paulus HE. Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc Natl Acad Sci U S A. 1980 May;77(5):2465–2469. [PubMed]
  • Krishnaiah KV, Walker LF, Borensztajn J, Schonfeld G, Getz GS. Apolipoprotein B variant derived from rat intestine. Proc Natl Acad Sci U S A. 1980 Jul;77(7):3806–3810. [PubMed]
  • Lock DR, Hockenberry D, Cunningham J, Hahm KS, Kantor O, Schonfeld G. Apolipoprotein B subspecies in chylomicrons isolated from a patient with chyluria. Am J Med. 1983 Aug;75(2):360–364. [PubMed]
  • Curtiss LK, Edgington TS. Immunochemical heterogeneity of human plasma apolipoprotein B. I. Apolipoprotein B binding of mouse hybridoma antibodies. J Biol Chem. 1982 Dec 25;257(24):15213–15221. [PubMed]
  • Tsao BP, Curtiss LK, Edgington TS. Immunochemical heterogeneity of human plasma apolipoprotein B. II. Expression of apolipoprotein B epitopes on native lipoproteins. J Biol Chem. 1982 Dec 25;257(24):15222–15228. [PubMed]
  • Marcel YL, Hogue M, Theolis R, Jr, Milne RW. Mapping of antigenic determinants of human apolipoprotein B using monoclonal antibodies against low density lipoproteins. J Biol Chem. 1982 Nov 25;257(22):13165–13168. [PubMed]
  • Milne RW, Weech PK, Blanchette L, Davignon J, Alaupovic P, Marcel YL. Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects. J Clin Invest. 1984 Mar;73(3):816–823. [PMC free article] [PubMed]
  • Wu AL, Windmueller HG. Variant forms of plasma apolipoprotein B. Hepatic and intestinal biosynthesis and heterogeneous metabolism in the rat. J Biol Chem. 1981 Apr 25;256(8):3615–3618. [PubMed]
  • Elovson J, Huang YO, Baker N, Kannan R. Apolipoprotein B is structurally and metabolically heterogeneous in the rat. Proc Natl Acad Sci U S A. 1981 Jan;78(1):157–161. [PubMed]
  • Sparks CE, Marsh JB. Metabolic heterogeneity of apolipoprotein B in the rat. J Lipid Res. 1981 Mar;22(3):519–527. [PubMed]
  • Van't Hooft FM, Hardman DA, Kane JP, Havel RJ. Apolipoprotein B (B-48) of rat chylomicrons is not a precursor of the apolipoprotein of low density lipoproteins. Proc Natl Acad Sci U S A. 1982 Jan;79(1):179–182. [PubMed]
  • Malloy MJ, Kane JP, Hardman DA, Hamilton RL, Dalal KB. Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein. J Clin Invest. 1981 May;67(5):1441–1450. [PMC free article] [PubMed]
  • Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974 Apr;20(4):470–475. [PubMed]
  • Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973 May;19(5):476–482. [PubMed]
  • Eibl H, Lands WE. A new, sensitive determination of phosphate. Anal Biochem. 1969 Jul;30(1):51–57. [PubMed]
  • Blaton V, De Buyzere M, Spincemaille J, Declercq B. Enzymic assay for phosphatidylcholine and sphingomyelin in serum. Clin Chem. 1983 May;29(5):806–809. [PubMed]
  • Warnick GR, Albers JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res. 1978 Jan;19(1):65–76. [PubMed]
  • Henderson LO, Herbert PN, Fredrickson DS, Heinen RJ, Easterling JC. Abnormal concentration and anomalous distribution of apolipoprotein A-I in Tangier disease. Metabolism. 1978 Feb;27(2):165–174. [PubMed]
  • Musliner TA, Garner PA, Henderson LO, Herbert PN. Radioimmunoassay of apolipoprotein a-ii. Arteriosclerosis. 1982 Mar-Apr;2(2):160–169. [PubMed]
  • LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed]
  • Rodbard D. Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem. 1974 Oct;20(10):1255–1270. [PubMed]
  • Reisfeld RA, Small PA., Jr Electrophoretic heterogeneity of polypeptide chains of specific antibodies. Science. 1966 May 27;152(3726):1253–1255. [PubMed]
  • Forte TM, Davis PA, Nordhausen RW, Glueck CJ. The electron microscopic structure of human umbilical cord blood lipoproteins. Artery. 1982;10(4):223–236. [PubMed]
  • Forte T, Nichols AV. Application of electron microscopy to the study of plasma lipoprotein structure. Adv Lipid Res. 1972;10:1–41. [PubMed]
  • Scanu AM, Aggerbeck LP, Kruski AW, Lim CT, Kayden HJ. A study of the abnormal lipoproteins in abetalipoproteinemia. J Clin Invest. 1974 Feb;53(2):440–453. [PMC free article] [PubMed]
  • Davis PA, Forte TM, Nichols AV, Blum CB. Umbilical cord blood lipoproteins. Isolation and characterization of high density lipoproteins. Arteriosclerosis. 1983 Jul-Aug;3(4):357–365. [PubMed]
  • Takashima Y, Kodama T, Iida H, Kawamura M, Aburatani H, Itakura H, Akanuma Y, Takaku F, Kawade M. Normotriglyceridemic abetalipoproteinemia in infancy: an isolated apolipoprotein B-100 deficiency. Pediatrics. 1985 Mar;75(3):541–546. [PubMed]
  • Rash JM, Rothblat GH, Sparks CE. Lipoprotein apolipoprotein synthesis by human hepatoma cells in culture. Biochim Biophys Acta. 1981 Nov 23;666(2):294–298. [PubMed]
  • Steinberg D, Grundy SM, Mok HY, Turner JD, Weinstein DB, Brown WV, Albers JJ. Metabolic studies in an unusual case of asymptomatic familial hypobetalipoproteinemia with hypolphalipoproteinemia and fasting chylomicronemia. J Clin Invest. 1979 Jul;64(1):292–301. [PMC free article] [PubMed]
  • Barker WC, Dayhoff MO. Evolution of lipoproteins deduced from protein sequence data. Comp Biochem Physiol B. 1977;57(4):309–315. [PubMed]
  • Heiss G, Tamir I, Davis CE, Tyroler HA, Rifkand BM, Schonfeld G, Jacobs D, Frantz ID., Jr Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study. Circulation. 1980 Feb;61(2):302–315. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation